TherapeuticsMD TXMD
NASDAQ TXMD
$1.80 -0.05 (-2.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Non Operating Investment Income (2022)

Updated

TherapeuticsMD's Non Operating Investment Income came in at $143.38 million for Q2 2022.

Analysis

TherapeuticsMD (TXMD) Non Operating Investment Income (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 TherapeuticsMD 20.83 Mn 20.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 143.38 Mn
API Access

TherapeuticsMD Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=TXMD&period=max&api_key=YOUR_API_KEY